Single-blind randomised controlled phase 1b trial of the safety and immunogenicity of lyophilised recombinant precipitated tropical malaria vaccine (BK-SE36) in Uganda.

Trial Profile

Single-blind randomised controlled phase 1b trial of the safety and immunogenicity of lyophilised recombinant precipitated tropical malaria vaccine (BK-SE36) in Uganda.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Sep 2016

At a glance

  • Drugs Malaria vaccine (Primary)
  • Indications Malaria
  • Focus Adverse reactions
  • Most Recent Events

    • 21 Apr 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 30 Jul 2009 Planned end date changed from 21 Nov 2009 to 21 Apr 2010 as reported by ISRCTN: Current Controlled Trials. record.
    • 30 Jul 2009 Planned initiation date changed from 23 Apr 2009 to 22 Sep 2009 as reported by ISRCTN: Current Controlled Trials. record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top